📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study. (2022)

First Author: Cristofanilli M

Attributed to: MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-22-0305

PubMed Identifier: 35552673

Publication URI: http://europepmc.org/abstract/MED/35552673

Type: Journal Article/Review

Volume: 28

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 16

ISSN: 1078-0432